SCHEMBL13005774

SCHEMBL13005774

O=C(O)/C=[N+](\[O-])Cc1ccccc1I

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TAAR1 Q96RJ0 1/20 0.35
HTR2A P28223 2/20 0.35
IDO1 P14902 2/20 0.34
HTR2C P28335 1/20 0.33
HTR7 P34969 1/20 0.33
HTR6 P50406 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SIGMAR1 Q99720 1/20 0.32
MAPT P10636 1/20 0.32
AKR1B1 P15121 1/20 0.32
MAPK8 P45983 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6045284 1.00 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C9CYP2C19TAAR1
SCHEMBL6045280 1.00 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C9CYP2C19TAAR1
SCHEMBL13005779 0.81 CYP1A2 (0.38) CYP1A2CYP2D6CYP2C9CYP2C19TAAR1
SCHEMBL5873408 0.77 CES2 (0.45) CYP2D6CYP2C19AKR1B1
SCHEMBL5873407 0.77 CES2 (0.45) CYP2D6CYP2C19AKR1B1
SCHEMBL13005770 0.72 TPMT (0.36) IDO1
SCHEMBL6045232 0.72 TPMT (0.36) IDO1
SCHEMBL2578821 0.72 TAAR1 (0.43) CYP1A2CYP2D6CYP2C9CYP2C19TAAR1
SCHEMBL13005771 0.71 CYP1A2 (0.38) CYP1A2CYP2D6CYP2C19HTR2AIDO1
SCHEMBL6044990 0.69 TAAR1 (0.43) CYP1A2CYP2D6CYP2C9CYP2C19TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed